Skyline Venture Partners V LP's Net Worth
$421 Million
Who is Skyline Venture Partners V LP?
Skyline Venture Partners V LP has an estimated net worth of $421 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MAKO Surgical Corp., SI-BONE, Inc., SUTRO BIOPHARMA INC, COLLEGIUM PHARMACEUTICAL, INC, and MERRILL CORP /NEW/ - FA.
SEC CIK
Skyline Venture Partners V LP's CIK is 0001419187
Past Insider Trading and Trends
2018 was Skyline Venture Partners V LP's most active year for acquiring shares with 9 total transactions. Skyline Venture Partners V LP's most active month to acquire stocks was the month of September. 2018 was Skyline Venture Partners V LP's most active year for disposing of shares, totalling 9 transactions. Skyline Venture Partners V LP's most active month to dispose stocks was the month of September. 2010 saw Skyline Venture Partners V LP paying a total of $5,790,000.00 for 600,000 shares, this is the most they've acquired in one year. In 2020 Skyline Venture Partners V LP cashed out on 1,000,000 shares for a total of $21,500,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.14% | -37.53K |
$26.02 | -$976,582.64 | 1.72M |
Scheduled
|
Feb 20
| ||
Form 4
|
∞
| 1.73M |
$15.00 |
—
| 1.73M |
Feb 4
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SI-BONE, Inc. (SIBN) Snapshot price: $20.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.18% | -1.00M |
$21.50 | -$21,500,000.00 | 2.82M |
Jan 27
| |||
Form 4
| -3.84% | -152.42K |
$18.40 | -$2,805,180.81 | 3.82M |
Aug 26
| |||
Form 4
| -1.18% | -47.58K |
$20.15 | -$958,469.62 | 3.97M |
Aug 21 - Aug 23
| |||
Form 4
| -9.05% | -400.00K |
$18.25 | -$7,300,000.00 | 4.02M |
Aug 12
| |||
Form 4
|
∞
| 4.42M |
$15.00 |
—
| 4.42M |
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SUTRO BIOPHARMA INC (STRO) Snapshot price: $4.685
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.96M |
—
|
—
| 1.96M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -27.12% | -800.00K |
—
|
—
| 2.15M |
Dec 5
| |||
Form 4
|
∞
| 2.95M |
$12.00 |
—
| 2.95M |
May 12
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRILL CORP /NEW/ - FA No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||